- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Lacidipine is a calcium channel blocker used to treat hypertension and other cardiovascular diseases. It works by blocking the influx of calcium ions into the smooth muscle cells of the heart and blood vessels, resulting in a decrease in blood pressure. It is available in both oral and intravenous formulations. Lacidipine is generally well tolerated, with few side effects. It is often used in combination with other antihypertensive medications.
The market for Lacidipine is growing due to its efficacy in treating hypertension and other cardiovascular diseases. It is increasingly being prescribed as a first-line treatment for hypertension, as well as for other cardiovascular conditions. The availability of both oral and intravenous formulations makes it a convenient and effective treatment option.
Some companies in the Lacidipine market include Pfizer, Novartis, Sanofi, Merck, and AstraZeneca. Show Less Read more